Latest filing published 23 Aug 2013 for Fresh Tracks Therapeutics, Inc., €13k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alain P. Rolland PhD: trading record in brief
Alain P. Rolland PhD discloses dealings in Fresh Tracks Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 5 January 2007 to 22 August 2013, the count stands at 75 filings.
Purchases make up the whole of the open-market record (7 purchases, €1,524). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 59 share grants. Since January 2013: 1 purchase and no sales on the market.
Half of the purchases are above €211 and half below.
The latest filing, published on 23 August 2013, reports a share grant of €13k in Fresh Tracks Therapeutics, Inc. The latest purchase dates back some time: it was published 5,045 days ago, on 15 January 2013. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alain P. Rolland PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,527 shares@ US$1.33Common Stock $.01 par valueSEC:0001181431-13-046389:0
- 1,097 shares@ US$3.72Common Stock $.01 par valueSEC:0001181431-13-039961:0
- 592 shares@ US$3.73Common Stock $.01 par valueSEC:0001181431-13-039961:1
- 1,317 shares@ US$3.61Common Stock $.01 par valueSEC:0001181431-13-039188:0
- 1,098 shares@ US$4.10Common Stock $.01 par valueSEC:0001181431-13-022171:0
- 593 shares@ US$4.13Common Stock $.01 par valueSEC:0001181431-13-022171:1
- 1,317 shares@ US$4.21Common Stock $.01 par valueSEC:0001181431-13-021473:0
- 22,092 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-13-003222:0Canonical exit: 11 Apr 2013 (T+90)
- 1,097 shares@ US$3.31Common Stock $.01 par valueSEC:0001181431-13-003222:1
- 2,370 shares@ US$3.31Common Stock $.01 par valueSEC:0001181431-13-003222:2
- 1,316 shares@ US$3.11Common Stock $.01 par valueSEC:0001181431-13-002696:0
- 768 shares@ US$3.28Common Stock $.01 par valueSEC:0001181431-13-002696:1
- 1,098 shares@ US$4.05Common Stock $.01 par valueSEC:0001181431-12-054490:0
- 1,318 shares@ US$4.32Common Stock $.01 par valueSEC:0001181431-12-054222:0
- 768 shares@ US$4.03Common Stock $.01 par valueSEC:0001181431-12-054222:1
- 768 shares@ US$3.58Common Stock $.01 par valueSEC:0001181431-12-040452:0
- 1,097 shares@ US$3.55Common Stock $.01 par valueSEC:0001181431-12-040452:1
- 1,317 shares@ US$3.59Common Stock $.01 par valueSEC:0001181431-12-040148:0
- 1,097 shares@ US$3.14Common Stock $.01 par valueSEC:0001181431-12-023816:0
- 1,317 shares@ US$3.34Common Stock $.01 par valueSEC:0001181431-12-023149:0
- 768 shares@ US$3.18Common Stock $.01 par valueSEC:0001181431-12-023149:1
- 27,000 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-12-002875:0Canonical exit: 12 Apr 2012 (T+90)
- 1,098 shares@ US$3.76Common Stock $.01 par valueSEC:0001181431-12-002336:0
- 5,269 shares@ US$3.64Common Stock $.01 par valueSEC:0001181431-12-002021:0
- 768 shares@ US$3.64Common Stock $.01 par valueSEC:0001181431-12-002021:1
25 of 73 declarations
